Pharmacokinetics and Biodistribution of Nanoparticles
Citations Over TimeTop 1% of 2008 papers
Abstract
Nanoparticles show their promise for improving the efficacy of drugs with a narrow therapeutic window or low bioavailability, such as anticancer drugs and nucleic acid-based drugs. The pharmacokinetics (PK) and tissue distribution of the nanoparticles largely define their therapeutic effect and toxicity. Chemical and physical properties of the nanoparticles, including size, surface charge, and surface chemistry, are important factors that determine their PK and biodistribution. The intracellular fate of the nanoparticles after cellular internalization that affects the drug bioavailability is also discussed. Strategies for overcoming barriers for intracellular delivery and drug release are presented. Finally, future directions for improving the PK of nanoparticles and perspectives in the field are discussed.
Related Papers
- → Large-Scale Screening Assay to Measure Epidermal Growth Factor Internalization(2000)12 cited
- → Role of carboxyl tail of the rat angiotensin II type 1A receptor in agonist-induced internalization of the receptor(1994)32 cited
- Antibody transport and internalization into tumours.(1990)
- → The Internalization and Therapeutic Activity of Antibody Drug Conjugates(2023)